key: cord-0829832-9inurpth
authors: Mouchtouris, Nhikolaos; Yu, Siyuan; Prashant, Giyarpuram; Nelson, Nicolas; Reyes, Maikerly; Gonzalez, Glenn; Smit, Rupert; Collopy, Sarah; Jabbour, Pascal; Sharan, Ashwini; Harrop, James; Rosenwasser, Robert; Evans, James J.
title: Telemedicine in Neurosurgery during the COVID-19 Outbreak: Where We Are One Year Later
date: 2022-03-16
journal: World Neurosurg
DOI: 10.1016/j.wneu.2022.03.037
sha: 6fef05b37db70f0912d13af1a7d8afab7ac5c2c7
doc_id: 829832
cord_uid: 9inurpth

Background The use of telemedicine skyrocketed in March 2020 upon the implementation of the shelter-in-place measures. Within the past year, the shelter-in-place measures were lifted and the COVID-19 vaccine was released, resulting in many neurosurgeons returning to in-person outpatient clinics. Our goal is to determine the extent of usage of telemedicine in neurosurgery one year into the pandemic. Methods A retrospective cohort study of patients who received neurosurgical care at a single institution from February 1–April 18 of the years 2020 and 2021 was performed. A total of 11,592 patients met the inclusion criteria. Of them, 1,465 patients underwent surgery, 7,083 were seen in clinic via an in-person meeting and 3,044 were assessed via telemedicine during the two study periods. Results At one year after the COVID-19 outbreak, telemedicine usage was at 81.3% of the initial volume upon the shelter-in-place measures implementation. In-person outpatient visits increased 40.2% from the early pandemic volume. Of the four divisions, telemedicine usage remained high in tumor and functional neurosurgery, significantly increased in vascular neurosurgery, and decreased in the spine division. Conclusion Telemedicine in neurosurgery clinics persisted one year after the COVID-19 outbreak. Even after the shelter-in-place measures were lifted, many neurosurgeons still use telemedicine, while the operative volume has remained stable. Due to the limited physical examination that can be performed via current telemedicine platforms, telemedicine use among spine providers is lower than the peak use during the early pandemic, while utilization has remained high among the tumor, vascular, and functional divisions.

outbreak. Even after the shelter-in-place measures were lifted, many neurosurgeons still use 24 telemedicine, while the operative volume has remained stable. Due to the limited physical 25 examination that can be performed via current telemedicine platforms, telemedicine use among 26 spine providers is lower than the peak use during the early pandemic, while utilization has 27 remained high among the tumor, vascular, and functional divisions. Since the implementation of the COVID-19 lockdown measures on March 13, 2020, 37 there has been a tremendous surge in the use of telemedicine in healthcare. 1-8 Before the 38 pandemic, Medicare beneficiaries used telemedicine for around 13,000 encounters per week. 39

This number reached nearly 1.7 million by end of April 2020. 1 Utilization of telehealth increased 40 dramatically across all surgical fields, 2 although this trend varied by location and may have 41 depended on state-specific legislation. Within the field of neurosurgery, studies have reported 42 single-center experiences of their transition to telemedicine upon the lockdown in 2020. 5-8 While 43

patients are generally satisfied with telemedicine, 4 challenges exist when compared to in-person 44 visits. 5, 9 These challenges include technical, network connection issues as well as concerns 45 about the quality of neurological assessments, post-operative incision checks, breaking bad news, 46 and guiding family discussions. Despite these concerns, a higher utilization of telemedicine has 47 persisted when compared to the pre-COVID period. 2 In our prior study, we reported our adoption 48 of telemedicine across several departments at Thomas Jefferson University and reported the 49 increase in utilization within all departments. 8 The aim of the current study is to demonstrate the 50 utilization of telemedicine one year after the COVID-19 outbreak and the distribution of usage 51 stratified by visit type and division. (Table 1) , but one year later they rose to 40.2% of the 99 original volume (Figure 2 ). The use of telemedicine increased 60-fold immediately upon the 100 COVID-19 lockdown to a weekly average of 212 visits. High-volume telemedicine use persisted 101

one year later at 172 visits, which was 81.3% of the initial surge. 102

The average number per week of operative cases, via in-person visits and telemedicine 103 visits, for the two study periods are shown in Table 1 Table 1 . year have facilitated the regional uptake of telemedicine. 10 In our experience (Figure 2) , the use 126 of telemedicine skyrocketed at the beginning of the pandemic and remained high one year later. 127

Moreover, our telemedicine volume has been comprised of a substantive volume of new patient 128 visits, as reflected in the stable number of operative cases (Figure 2 ). While acknowledging that 129 J o u r n a l P r e -p r o o f our data represents the site-specific potential of telemedicine uptake rather than a homogeneous 130 national phenomenon, our findings demonstrate that the initial increase in telemedicine 131 utilization may indeed persist as lockdown restrictions are lifted, and it has become an integral 132 component of outpatient neurosurgical care. shown that telemedicine is suitable for developing lasting physician-patient relationships, 162 discussing of surgical procedures, obtaining informed consent, tracking progress post-163 operatively, and answering family questions. Our findings suggest that telemedicine has proven 164 an adequate platform even for discussing sensitive topics like imaging findings, the need for 165 surgery, disease recurrence, and other forms of bad news. Furthermore, providers in the 166 department have also been able to utilize telemedicine for multidisciplinary meetings as well as increase in the number of in-person visits noted in our second study period, however, the 185 proportion of telemedicine visits to the total outpatient visits has remained stable throughout our 186 study period. These fluctuations are related to the ongoing pandemic, the regional control, the 187 remaining restrictions, and their impact on the operative volume. Nonetheless, our trends remain 188 consistent, suggesting the long-term integration of telemedicine into neurosurgical care. We have 189

shown that telemedicine remained a valuable modality in outpatient neurosurgery, even when in-190 person visits became an option again, and we look forward to improvements in the functionality 191 of telemedicine platforms that might further extend value to the field. 

among spine providers is lower than the peak use of

Early Impact Of CMS Expansion Of Medicare Telehealth During COVID-19

Use of Telehealth by Surgical Specialties During the COVID-19

Teledermatology, teledermatopathology, interstate 232 dermatopathology and the law

Ambulatory neurosurgery in the COVID-19 era: patient and provider 234 satisfaction with telemedicine

Telemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A 236 Neurosurgical Perspective

Telemedicine Utilization in Neurosurgery During the COVID-19

Pandemic: A Glimpse Into the Future?

Telemedicine in Neurosurgery: Lessons Learned from a Systematic 241 Review of the Literature for the COVID-19 Era and Beyond

Telemedicine in Neurosurgery: Lessons Learned and 244 Transformation of Care During the COVID-19 Pandemic

Neurosurgery and Telemedicine in the United 247 States: Assessment of the Risks and Opportunities

Implementation, relevance, and virtual adaptation of neuro-oncological